Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
34.10
Dollar change
-0.06
Percentage change
-0.18
%
IndexRUT P/E- EPS (ttm)-1.02 Insider Own3.91% Shs Outstand14.29M Perf Week0.15%
Market Cap487.49M Forward P/E151.56 EPS next Y0.23 Insider Trans-1.24% Shs Float13.74M Perf Month-7.36%
Income-14.41M PEG- EPS next Q-0.09 Inst Own85.63% Short Float4.38% Perf Quarter-11.57%
Sales125.45M P/S3.89 EPS this Y44.79% Inst Trans-9.67% Short Ratio2.40 Perf Half Y-13.25%
Book/sh7.82 P/B4.36 EPS next Y227.36% ROA-8.38% Short Interest0.60M Perf Year6.56%
Cash/sh2.11 P/C16.17 EPS next 5Y- ROE-12.32% 52W Range25.17 - 42.44 Perf YTD-13.89%
Dividend Est.- P/FCF- EPS past 5Y- ROI-10.02% 52W High-19.65% Beta1.19
Dividend TTM- Quick Ratio4.29 Sales past 5Y5.69% Gross Margin71.99% 52W Low35.48% ATR (14)1.00
Dividend Ex-Date- Current Ratio5.45 EPS Y/Y TTM-359.07% Oper. Margin-1.39% RSI (14)34.79 Volatility2.78% 3.09%
Employees389 Debt/Eq0.30 Sales Y/Y TTM-9.23% Profit Margin-11.48% Recom3.00 Target Price43.00
Option/ShortYes / Yes LT Debt/Eq0.29 EPS Q/Q-360.68% Payout- Rel Volume0.40 Prev Close34.16
Sales Surprise-10.32% EPS Surprise65.72% Sales Q/Q-2.06% EarningsJan 30 BMO Avg Volume250.34K Price34.10
SMA20-3.53% SMA50-9.47% SMA200-12.02% Trades Volume101,289 Change-0.18%
Date Action Analyst Rating Change Price Target Change
Jun-13-23Upgrade Needham Hold → Buy $36
Feb-13-23Downgrade Needham Buy → Hold
Jul-23-20Upgrade Needham Hold → Buy
Dec-11-19Downgrade Needham Buy → Hold
Nov-01-19Downgrade Lake Street Buy → Hold $75 → $50
Aug-01-19Reiterated Needham Buy $65 → $68
May-02-19Reiterated Needham Buy $74 → $65
May-02-19Reiterated Lake Street Buy $90 → $75
Feb-21-19Reiterated Needham Buy $69 → $74
May-16-18Reiterated Needham Buy $46 → $55
Feb-03-25 09:35AM
07:00AM
Jan-30-25 09:30AM
08:20AM
07:24AM
07:00AM Loading…
07:00AM
Jan-14-25 09:35AM
Jan-03-25 12:00PM
Dec-06-24 11:31AM
Nov-22-24 01:01AM
Nov-12-24 12:45PM
Nov-06-24 08:20AM
07:28AM
07:00AM
Oct-30-24 02:30PM
07:00AM Loading…
Oct-01-24 07:00AM
Sep-06-24 09:55AM
Sep-05-24 09:35AM
Aug-15-24 09:35AM
Jul-31-24 10:30AM
08:20AM
07:16AM
07:00AM
Jun-11-24 10:38AM
Jun-10-24 07:00AM
May-31-24 11:31AM
11:28AM
04:45AM
May-29-24 04:07PM
07:00AM
10:49AM Loading…
May-20-24 10:49AM
May-03-24 01:12PM
May-02-24 12:38PM
03:01AM
May-01-24 02:05PM
11:54AM
09:30AM
08:30AM
07:32AM
07:00AM
Apr-19-24 07:00AM
Apr-17-24 10:01AM
Mar-20-24 11:29AM
Feb-27-24 08:00AM
Feb-02-24 10:11AM
09:58AM
Feb-01-24 01:03PM
09:30AM
08:10AM
07:11AM
07:00AM
Jan-23-24 10:15AM
Jan-22-24 07:30AM
Jan-16-24 07:30AM
07:30AM
Dec-14-23 07:14AM
Dec-12-23 11:31AM
Nov-16-23 07:30AM
07:30AM
Nov-14-23 04:05PM
Nov-11-23 02:10PM
Nov-09-23 12:44PM
12:33AM
Nov-08-23 03:10PM
09:30AM
08:00AM
07:30AM
Nov-07-23 07:30AM
07:30AM
Oct-31-23 07:30AM
Oct-10-23 11:28AM
07:30AM
Sep-12-23 10:42AM
Sep-06-23 11:04AM
Aug-15-23 10:20AM
Aug-09-23 05:05PM
Aug-03-23 01:03PM
06:47AM
Aug-02-23 09:30AM
08:55AM
07:47AM
07:31AM
Jul-26-23 10:02AM
Jul-12-23 07:30AM
Jun-28-23 11:31AM
Jun-23-23 10:27AM
Jun-21-23 06:10AM
01:53AM
Jun-20-23 11:54AM
06:30AM
Jun-16-23 11:20AM
Jun-14-23 07:30AM
01:18AM
Jun-13-23 01:11PM
May-25-23 04:05PM
May-16-23 09:55AM
May-15-23 09:35AM
May-14-23 08:21AM
May-03-23 01:35PM
Apr-27-23 10:29AM
Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device, In Vitro Diagnostics, and Corporate. The Medical Device segment designs, develops, and manufactures vascular interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment is composed of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KNIGHT SUSAN EDirectorJan 24 '25Option Exercise27.307,358200,87342,506Jan 28 05:39 PM
Arens Timothy J.Chief Financial OfficerNov 26 '24Sale39.447,009276,45370,350Nov 27 04:30 PM
TIMOTHY ARENSOfficerNov 26 '24Proposed Sale39.447,009276,453Nov 26 04:53 PM
Stich Joseph J.SVP of HR, President IVDAug 21 '24Option Exercise33.2021,285706,66283,405Aug 23 04:06 PM
Maharaj Gary RPresident & CEOAug 21 '24Option Exercise33.2061,0172,025,764253,151Aug 23 04:05 PM
OLSON CHARLES WSVP, Medical Device CoatingsAug 16 '24Option Exercise33.2018,447612,44070,698Aug 20 04:25 PM
Arens Timothy J.Chief Financial OfficerAug 16 '24Option Exercise33.2018,447612,44094,088Aug 20 04:24 PM